19
Jun
2024

Beijing Kawin Technology Share-Holding Co., Ltd.

Exhibitor at CPHI & PMEC China 2024 stand W4G68, Bio Pharma
About Us

Focusing on viral and immune diseases, Kawin can offer matured products based upon our specialty in interferon strain management, in EP standard. We also can provide product licensing opportunities like our portfolio of Glycyrrhizin products that have been popularized in dermatology and hepatology.  Transfer of Interferon & GCSF (both conventional & pegylated) are open to discussion.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2023
    On CPHI since
  • 1
    Certificates
  • 500 - 999
    Employees
Company types
Biopharmaceutical company
Primary activities
API Producer
Biopharmaceutical
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
View company profile
Contact info
  • 01087120833
  • Website
  • No.6 Rongjing East Street, BDA, Beijing, China, 100176, Beijing, China
Show contact info Hide contact info
Event information
CPHI & PMEC China 2024
  • 19 - 21 June 2024
  • Shanghai New International Expo Center
  • Visit us at stand W4G68, Bio Pharma

Products Featured at CPHI & PMEC China 2024